Rare diseases
Investigational molecules
Locations
Back to France2 221 clinical trials in Lyon, France across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer
FranceStudy on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure
FranceStudy on ARGX-117 for Improving Kidney Function in Patients with Delayed Graft Function After Deceased Donor Transplant
FranceStudy of BMS-986449 and Nivolumab for Patients with Advanced Solid Tumors
FranceStudy on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy
FranceStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
FranceStudy on Brentuximab Vedotin, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
FranceStudy on BP1.4979 for Treating Binge Eating Disorder in Women with Moderate to Severe Symptoms
FranceStudy of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma
FranceStudy on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis
FranceStudy of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis
FranceStudy on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for endometrial carcinoma, bladder cancer, and various solid tumors. Current research explores combination therapies with novel immunotherapy approaches.
Multiple studies are evaluating targeted therapies and immunological approaches for various tumor types.
Groundbreaking research in immune system modulation and infectious disease prevention, including studies on COVID-19 vaccines and immune response in critical conditions.
Focus on developing innovative vaccination strategies and immune system interventions.
Studies addressing long-term health conditions, with particular emphasis on kidney disease, cardiovascular health, and metabolic disorders.
Innovative approaches combining established and experimental treatments for improved patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
